Table 4. Comparison of Liraglutide with OADs and Insulin.

BMI, body mass index; HbA1C, glycated hemoglobin; OADs, oral anti-diabetics

S. No	.Variables	Pre-treatment (Mean)	Post-treatment (Mean)	Difference	p-Value
	Group 1: Liraglutide as Monotherapy (n=18)
1	Weight	91.77	85.38	6.39	<0.001
2	BMI	32.85	30.26	2.59	<0.001
3	HbA1C	8.58	6.79	1.79	<0.001
4	Fasting Glucose Levels	189.72	118.22	71.5	<0.001
5	Systolic Blood Pressure	130.83	117.77	13.06	0.001
6	Diastolic Blood Pressure	88.61	81.11	7.50	<0.001
	Group 2: Liraglutide with OADs (n=25)
1	Weight	93.88	89.09	4.79	<0.001
2	BMI	33.36	31.58	1.78	<0.001
3	HbA1C	9.73	7.98	1.75	<0.001
4	Fasting Glucose Levels	202.92	124.40	78.52	<0.001
5	Systolic Blood Pressure	140.56	126.40	14.16	<0.001
6	Diastolic Blood Pressure	89.52	83.84	5.68	0.008
	Group 3: Liraglutide with Insulin (n=27)
1	Weight	95.00	89.60	5.4	<0.001
2	BMI	34.78	32.70	2.08	<0.001
3	HbA1C	10.08	8.32	1.76	<0.001
4	Fasting Glucose Levels	239.25	143.03	96.22	<0.001
5	Systolic Blood Pressure	137.22	126.29	10.93	<0.001
6	Diastolic Blood Pressure	87.77	83.70	4.07	0.068